(LVS) Las Vegas Sands - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5178341070
Stock: Casino, Hotel, Retail, Convention, Entertainment
Total Rating 52
Risk 40
Buy Signal 0.42
| Risk 5d forecast | |
|---|---|
| Volatility | 36.1% |
| Relative Tail Risk | -9.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 17.51 |
| Character TTM | |
|---|---|
| Beta | 0.854 |
| Beta Downside | 1.420 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.18% |
| CAGR/Max DD | -0.01 |
EPS (Earnings per Share)
Revenue
Description: LVS Las Vegas Sands March 01, 2026
Las Vegas Sands Corp. (NYSE:LVS) operates a portfolio of high-end integrated resorts in Macau-including The Venetian, The Londoner, The Parisian, The Plaza, Four Seasons, and Sands Macau-and Marina Bay Sands in Singapore. Each resort combines luxury accommodations, casino gaming, entertainment venues, retail malls, convention space, and celebrity-chef restaurants under a single brand.
In its FY 2025 results released in February 2026, LVS reported revenue of $12.5 billion, a 7% year-over-year increase driven largely by a rebound in gaming revenue (+8%) and higher hotel RevPAR in Macau ($350, up 6%). Adjusted EBITDA reached $5.2 billion, delivering an EBITDA margin of 41.6%, while average occupancy across its Macau properties held at 92% throughout the year.
Key drivers for the sector remain robust Asian tourism growth and regulatory changes. Macau’s gaming tax was reduced from 35% to 30% in 2025, improving net gaming margins, while Singapore welcomed a 5% rise in international visitor arrivals, bolstering non-gaming spend at Marina Bay Sands. Additionally, the easing of travel restrictions across Greater China continues to fuel demand for integrated resort experiences.
For a deeper quantitative dive, you might explore LVS’s valuation metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.63b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.60 > 1.0 |
| NWC/Revenue: 4.69% < 20% (prev -13.37%; Δ 18.06% < -1%) |
| CFO/TA 0.14 > 3% & CFO 3.02b > Net Income 1.63b |
| Net Debt (12.30b) to EBITDA (4.50b): 2.73 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (678.0m) vs 12m ago -8.01% < -2% |
| Gross Margin: 28.18% > 18% (prev 0.37%; Δ 2781 % > 0.5%) |
| Asset Turnover: 61.13% > 50% (prev 54.67%; Δ 6.46% > 0%) |
| Interest Coverage Ratio: 3.97 > 6 (EBITDA TTM 4.50b / Interest Expense TTM 746.0m) |
Altman Z'' 2.00
| A: 0.03 (Total Current Assets 4.83b - Total Current Liabilities 4.22b) / Total Assets 21.92b |
| B: 0.20 (Retained Earnings 4.39b / Total Assets 21.92b) |
| C: 0.14 (EBIT TTM 2.96b / Avg Total Assets 21.29b) |
| D: 0.22 (Book Value of Equity 4.46b / Total Liabilities 19.99b) |
| Altman-Z'' Score: 2.00 = BBB |
Beneish M -1.59
| DSRI: 1.54 (Receivables 742.0m/417.0m, Revenue 13.02b/11.30b) |
| GMI: 1.30 (GM 28.18% / 36.76%) |
| AQI: 2.13 (AQ_t 0.25 / AQ_t-1 0.12) |
| SGI: 1.15 (Revenue 13.02b / 11.30b) |
| TATA: -0.06 (NI 1.63b - CFO 3.02b) / TA 21.92b) |
| Beneish M-Score: -1.59 (Cap -4..+1) = CCC |
What is the price of LVS shares?
As of March 02, 2026, the stock is trading at USD 56.72 with a total of 5,698,685 shares traded.
Over the past week, the price has changed by +1.79%, over one month by +2.47%, over three months by -17.95% and over the past year by +27.45%.
Over the past week, the price has changed by +1.79%, over one month by +2.47%, over three months by -17.95% and over the past year by +27.45%.
Is LVS a buy, sell or hold?
Las Vegas Sands has received a consensus analysts rating of 4.44.
Therefore, it is recommended to buy LVS.
- StrongBuy: 12
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LVS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.9 | 23.2% |
| Analysts Target Price | 69.9 | 23.2% |
LVS Fundamental Data Overview February 28, 2026
P/E Trailing = 23.8085
P/E Forward = 16.8067
P/S = 2.9062
P/B = 18.98
P/EG = 0.8558
Revenue TTM = 13.02b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 4.50b USD
Long Term Debt = 14.66b USD (from longTermDebt, last quarter)
Short Term Debt = 1.15b USD (from shortTermDebt, last quarter)
Debt = 16.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.30b USD (from netDebt column, last quarter)
Enterprise Value = 50.13b USD (37.83b + Debt 16.14b - CCE 3.84b)
Interest Coverage Ratio = 3.97 (Ebit TTM 2.96b / Interest Expense TTM 746.0m)
EV/FCF = 27.02x (Enterprise Value 50.13b / FCF TTM 1.85b)
FCF Yield = 3.70% (FCF TTM 1.85b / Enterprise Value 50.13b)
FCF Margin = 14.25% (FCF TTM 1.85b / Revenue TTM 13.02b)
Net Margin = 12.50% (Net Income TTM 1.63b / Revenue TTM 13.02b)
Gross Margin = 28.18% ((Revenue TTM 13.02b - Cost of Revenue TTM 9.35b) / Revenue TTM)
Gross Margin QoQ = 20.44% (prev 28.34%)
Tobins Q-Ratio = 2.29 (Enterprise Value 50.13b / Total Assets 21.92b)
Interest Expense / Debt = 1.18% (Interest Expense 191.0m / Debt 16.14b)
Taxrate = 18.69% (103.0m / 551.0m)
NOPAT = 2.41b (EBIT 2.96b * (1 - 18.69%))
Current Ratio = 1.14 (Total Current Assets 4.83b / Total Current Liabilities 4.22b)
Debt / Equity = 10.15 (Debt 16.14b / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 2.73 (Net Debt 12.30b / EBITDA 4.50b)
Debt / FCF = 6.63 (Net Debt 12.30b / FCF TTM 1.85b)
Total Stockholder Equity = 1.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.64% (Net Income 1.63b / Total Assets 21.92b)
RoE = 82.89% (Net Income TTM 1.63b / Total Stockholder Equity 1.96b)
RoCE = 17.81% (EBIT 2.96b / Capital Employed (Equity 1.96b + L.T.Debt 14.66b))
RoIC = 13.93% (NOPAT 2.41b / Invested Capital 17.27b)
WACC = 6.64% (E(37.83b)/V(53.97b) * Re(9.06%) + D(16.14b)/V(53.97b) * Rd(1.18%) * (1-Tc(0.19)))
Discount Rate = 9.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.55%
[DCF] Terminal Value 76.87% ; FCFF base≈1.76b ; Y1≈1.16b ; Y5≈527.9m
[DCF] Fair Price = 2.10 (EV 13.71b - Net Debt 12.30b = Equity 1.41b / Shares 671.9m; r=6.64% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 87.48 | EPS CAGR: 133.2% | SUE: 0.64 | # QB: 0
Revenue Correlation: 86.26 | Revenue CAGR: 43.45% | SUE: 2.08 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=-0.003 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-12-31): EPS=3.15 | Chg7d=+0.021 | Chg30d=-0.063 | Revisions Net=-2 | Growth EPS=+4.8% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=3.72 | Chg7d=+0.025 | Chg30d=-0.052 | Revisions Net=+0 | Growth EPS=+18.1% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: -0.25 (3 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.9% (Discount Rate 9.1% - Earnings Yield 4.2%)
[Growth] Growth Spread = +0.0% (Analyst 4.9% - Implied 4.9%)
P/E Forward = 16.8067
P/S = 2.9062
P/B = 18.98
P/EG = 0.8558
Revenue TTM = 13.02b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 4.50b USD
Long Term Debt = 14.66b USD (from longTermDebt, last quarter)
Short Term Debt = 1.15b USD (from shortTermDebt, last quarter)
Debt = 16.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.30b USD (from netDebt column, last quarter)
Enterprise Value = 50.13b USD (37.83b + Debt 16.14b - CCE 3.84b)
Interest Coverage Ratio = 3.97 (Ebit TTM 2.96b / Interest Expense TTM 746.0m)
EV/FCF = 27.02x (Enterprise Value 50.13b / FCF TTM 1.85b)
FCF Yield = 3.70% (FCF TTM 1.85b / Enterprise Value 50.13b)
FCF Margin = 14.25% (FCF TTM 1.85b / Revenue TTM 13.02b)
Net Margin = 12.50% (Net Income TTM 1.63b / Revenue TTM 13.02b)
Gross Margin = 28.18% ((Revenue TTM 13.02b - Cost of Revenue TTM 9.35b) / Revenue TTM)
Gross Margin QoQ = 20.44% (prev 28.34%)
Tobins Q-Ratio = 2.29 (Enterprise Value 50.13b / Total Assets 21.92b)
Interest Expense / Debt = 1.18% (Interest Expense 191.0m / Debt 16.14b)
Taxrate = 18.69% (103.0m / 551.0m)
NOPAT = 2.41b (EBIT 2.96b * (1 - 18.69%))
Current Ratio = 1.14 (Total Current Assets 4.83b / Total Current Liabilities 4.22b)
Debt / Equity = 10.15 (Debt 16.14b / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 2.73 (Net Debt 12.30b / EBITDA 4.50b)
Debt / FCF = 6.63 (Net Debt 12.30b / FCF TTM 1.85b)
Total Stockholder Equity = 1.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.64% (Net Income 1.63b / Total Assets 21.92b)
RoE = 82.89% (Net Income TTM 1.63b / Total Stockholder Equity 1.96b)
RoCE = 17.81% (EBIT 2.96b / Capital Employed (Equity 1.96b + L.T.Debt 14.66b))
RoIC = 13.93% (NOPAT 2.41b / Invested Capital 17.27b)
WACC = 6.64% (E(37.83b)/V(53.97b) * Re(9.06%) + D(16.14b)/V(53.97b) * Rd(1.18%) * (1-Tc(0.19)))
Discount Rate = 9.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.55%
[DCF] Terminal Value 76.87% ; FCFF base≈1.76b ; Y1≈1.16b ; Y5≈527.9m
[DCF] Fair Price = 2.10 (EV 13.71b - Net Debt 12.30b = Equity 1.41b / Shares 671.9m; r=6.64% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 87.48 | EPS CAGR: 133.2% | SUE: 0.64 | # QB: 0
Revenue Correlation: 86.26 | Revenue CAGR: 43.45% | SUE: 2.08 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=-0.003 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-12-31): EPS=3.15 | Chg7d=+0.021 | Chg30d=-0.063 | Revisions Net=-2 | Growth EPS=+4.8% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=3.72 | Chg7d=+0.025 | Chg30d=-0.052 | Revisions Net=+0 | Growth EPS=+18.1% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: -0.25 (3 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.9% (Discount Rate 9.1% - Earnings Yield 4.2%)
[Growth] Growth Spread = +0.0% (Analyst 4.9% - Implied 4.9%)